SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,633.65 -225.34
( -0.30%)

Global Indices

Nasdaq

52,073.35 369.71
(0.72%)

Dow Jones

7,785.28 113.78
(1.48%)

Hang Seng

65,040.24 903.99
(1.41%)

Nikkei 225

10,737.46 78.33
(0.73%)

Forex

USD-INR

95.99 0.12
(0.12%)

EUR-INR

110.24 0.24
(0.22%)

GBP-INR

128.54 0.36
(0.28%)

JPY-INR

0.61 0.00
(-0.53%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

658.9991894

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

14.64

96940.36

EPS(TTM)

Face Value()

Div & Yield %

144.81

0.85

Date	Headline
09-Sep-2026	Lupin Ltd down for fifth straight session
04-Sep-2026	Lupin receives USFDA approval for Modafinil Tablets USP
25-Aug-2026	Lupin allots 30,967 equity shares under ESOP
20-Aug-2026	Lupin inks pact with Tenpoint Therapeutics to commercialize YUVEZZI in select countries
17-Aug-2026	Lupin receives USFDA approval for Pitolisant Tablets, 4.45 mg and 17.8 mg
11-Aug-2026	Lupin Ltd slips for fifth straight session
10-Aug-2026	Lupin receives USFDA approval for Sodium Zirconium Cyclosilicate for Oral Suspension
07-Aug-2026	Lupin consolidated net profit rises 16.08% in the June 2026 quarter
31-Jul-2026	Lupin launches Sugammadex Injection in U.S. market
31-Jul-2026	Lupin receives USFDA approval for Diazepam Injection USP

<< < 1 2 3 ... > >>

74,633.65 -225.34 ( -0.30%)

52,073.35 369.71 (0.72%)

7,785.28 113.78 (1.48%)

65,040.24 903.99 (1.41%)

10,737.46 78.33 (0.73%)

95.99 0.12 (0.12%)

110.24 0.24 (0.22%)

128.54 0.36 (0.28%)

0.61 0.00 (-0.53%)